| Modulation of mismatch repair and genomic stability by miR-155 N Valeri, P Gasparini, M Fabbri, C Braconi, A Veronese, F Lovat, B Adair, ... Proceedings of the National Academy of Sciences 107 (15), 6982-6987, 2010 | 440 | 2010 |
| MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) N Valeri, P Gasparini, C Braconi, A Paone, F Lovat, M Fabbri, KM Sumani, ... Proceedings of the National Academy of Sciences 107 (49), 21098-21103, 2010 | 432 | 2010 |
| MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer G Di Leva, P Gasparini, C Piovan, A Ngankeu, M Garofalo, C Taccioli, ... JNCI: Journal of the National Cancer Institute 102 (10), 706-721, 2010 | 421 | 2010 |
| Reprogramming of miRNA networks in cancer and leukemia S Volinia, M Galasso, S Costinean, L Tagliavini, G Gamberoni, A Drusco, ... Genome research 20 (5), 589-599, 2010 | 410 | 2010 |
| MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ... Cancer cell 25 (4), 469-483, 2014 | 322 | 2014 |
| Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma C Braconi, N Valeri, T Kogure, P Gasparini, N Huang, GJ Nuovo, ... Proceedings of the National Academy of Sciences 108 (2), 786-791, 2011 | 256 | 2011 |
| miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, ... Oncogene 31 (5), 634-642, 2012 | 242 | 2012 |
| Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ... Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014 | 218 | 2014 |
| Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer L Cascione, P Gasparini, F Lovat, S Carasi, A Pulvirenti, A Ferro PloS one 8 (2), e55910, 2013 | 200 | 2013 |
| Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status G Di Leva, C Piovan, P Gasparini, A Ngankeu, C Taccioli, D Briskin, ... PLoS genetics 9 (3), e1003311, 2013 | 189 | 2013 |
| Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression L Casadei, F Calore, CJ Creighton, M Guescini, K Batte, OH Iwenofu, ... Cancer research 77 (14), 3846-3856, 2017 | 171 | 2017 |
| microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers P Gasparini, L Cascione, M Fassan, F Lovat, G Guler, S Balci, C Irkkan, ... Oncotarget 5 (5), 1174, 2014 | 162 | 2014 |
| In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation F Pichiorri, D Palmieri, L De Luca, J Consiglio, J You, A Rocci, T Talabere, ... Journal of Experimental Medicine 210 (5), 951-968, 2013 | 153 | 2013 |
| Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes C Braconi, N Valeri, P Gasparini, N Huang, C Taccioli, G Nuovo, T Suzuki, ... Clinical Cancer Research 16 (3), 957-966, 2010 | 138 | 2010 |
| miR-15b/16-2 deletion promotes B-cell malignancies F Lovat, M Fassan, P Gasparini, L Rizzotto, L Cascione, M Pizzi, ... Proceedings of the National Academy of Sciences 112 (37), 11636-11641, 2015 | 119 | 2015 |
| Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options P Gasparini, M Fassan, L Cascione, G Guler, S Balci, C Irkkan, C Paisie, ... PLoS One 9 (2), e88525, 2014 | 112 | 2014 |
| MIR21 drives resistance to heat shock protein 90 inhibition in cholangiocarcinoma A Lampis, P Carotenuto, G Vlachogiannis, L Cascione, S Hedayat, ... Gastroenterology 154 (4), 1066-1079. e5, 2018 | 111 | 2018 |
| microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers CCM Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D ... Proc Natl Acad Sci U S A. 112 (48), 2015 | 84* | 2015 |
| TWIST1-induced miR-424 reversibly drives mesenchymal programming while inhibiting tumor initiation DJ Drasin, AL Guarnieri, D Neelakantan, J Kim, JH Cabrera, CA Wang, ... Cancer research 75 (9), 1908-1921, 2015 | 70 | 2015 |
| Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression R Galli, A Paone, M Fabbri, N Zanesi, F Calore, L Cascione, M Acunzo, ... Proceedings of the National Academy of Sciences 110 (24), 9812-9817, 2013 | 68 | 2013 |
